Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MICHAEL AURASH ZADEH

Allopathic & Osteopathic Physicians Surgery

NPI
1467673699
CMS profile
690115
Location
SHERMAN OAKS, CA

General Payments · PY2018–2024

$28,266.13

  • Reported across 97 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$7,935.80

12 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $7,755.63 4
Lilly USA, LLC $51.88 2
Galderma Laboratories, L.P. $36.99 2
Daiichi Sankyo Inc. $29.98 1
JAZZ PHARMACEUTICALS INC. $27.04 1
BIOTISSUE HOLDINGS INC. $21.00 1
REVANCE THERAPEUTICS, INC. $13.28 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $535.72 19
PY2019 $1,290.30 31
PY2020 $140.94 7
PY2021 $5,118.77 8
PY2022 $10,386.64 14
PY2023 $2,857.96 6
PY2024 $7,935.80 12

Payment records · PY2024 (12)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $3,636.47 01/03/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1106386704 CMS
ABBVIE INC. $1,363.53 01/29/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1106386706 CMS
ABBVIE INC. $2,750.00 04/08/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1106386708 CMS
ABBVIE INC. $5.63 06/15/2024 Food and Beverage Undisputed 01/23/2026 1106386710 CMS
BIOTISSUE HOLDINGS INC. $21.00 09/30/2024 Food and Beverage Undisputed 01/23/2026 1148763844 CMS
Daiichi Sankyo Inc. $29.98 10/25/2024 Food and Beverage Undisputed 01/23/2026 1089501276 CMS
Galderma Laboratories, L.P. $15.16 04/12/2024 Food and Beverage Undisputed 01/23/2026 1145337023 CMS
Galderma Laboratories, L.P. $21.83 06/11/2024 Food and Beverage Undisputed 01/23/2026 1145337025 CMS
JAZZ PHARMACEUTICALS INC. $27.04 04/24/2024 Food and Beverage Undisputed 01/23/2026 1150216584 CMS
Lilly USA, LLC $31.10 03/21/2024 Food and Beverage Undisputed 01/23/2026 1135193374 CMS
Lilly USA, LLC $20.78 06/26/2024 Food and Beverage Undisputed 01/23/2026 1135191841 CMS
REVANCE THERAPEUTICS, INC. $13.28 06/26/2024 Food and Beverage Undisputed 01/23/2026 1147932392 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.